Multiple Distinct Forms of CD8+ T Cell Cross-Reactivity and Specificities Revealed after 2009 H1N1 Influenza A Virus Infection in Mice

PLoS ONE

Volumn 7, Issue 9, 2012, Pages

  Guo, Hailong ^a   Topham, David J ^b  

^a ROCHESTER GENERAL HOSPITAL   (United States)

^b UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; GAMMA INTERFERON; NUCLEOPROTEIN; RNA POLYMERASE;

2009 H1N1 INFLUENZA; AMINO ACID SUBSTITUTION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN RECOGNITION; ANTIGENICITY; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL SPECIFICITY; CELLULAR IMMUNITY; CONTROLLED STUDY; CROSS REACTION; CYTOKINE PRODUCTION; FEMALE; IMMUNOGENICITY; MOUSE; NONHUMAN; SEQUENCE HOMOLOGY; T LYMPHOCYTE;

AMINO ACID SUBSTITUTION; ANIMALS; ANTIGENS, VIRAL; CD8-POSITIVE T-LYMPHOCYTES; CROSS PROTECTION; CROSS REACTIONS; DNA-DIRECTED DNA POLYMERASE; EPITOPES, T-LYMPHOCYTE; HUMANS; IMMUNOLOGIC MEMORY; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA A VIRUS, H3N2 SUBTYPE; MICE; NUCLEOPROTEINS; OLIGOPEPTIDES; ORTHOMYXOVIRIDAE INFECTIONS; T-CELL ANTIGEN RECEPTOR SPECIFICITY;

INFLUENZA A VIRUS; MUS; ORTHOMYXOVIRIDAE;

EID: 84866897289     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0046166     Document Type: Article

References (36)

1. Doherty PC, Turner SJ, (2009) Thinking about broadly cross-reactive vaccines. Clin Pharmacol Ther 85: 665-668.
2. Townsend AR, Rothbard J, Gotch FM, Bahadur G, Wraith D, et al. (1986) The epitopes of influenza nucleoprotein recognized by cytotoxic T lymphocytes can be defined with short synthetic peptides. Cell 44: 959-968.
3. Belz GT, Xie W, Altman JD, Doherty PC, (2000) A previously unrecognized H-2D(b)-restricted peptide prominent in the primary influenza A virus-specific CD8(+) T-cell response is much less apparent following secondary challenge. J Virol 74: 3486-3493.
4. Ray SJ, Franki SN, Pierce RH, Dimitrova S, Koteliansky V, et al. (2004) The collagen binding alpha1beta1 integrin VLA-1 regulates CD8 T cell-mediated immune protection against heterologous influenza infection. Immunity 20: 167-179.
5. Bennink J, Effros RB, Doherty PC, (1978) Influenzal pneumonia: early appearance of cross-reactive T cells in lungs of mice primed with heterologous type A viruses. Immunology 35: 503-509.
6. Kreijtz JH, Bodewes R, van Amerongen G, Kuiken T, Fouchier RA, et al. (2007) Primary influenza A virus infection induces cross-protective immunity against a lethal infection with a heterosubtypic virus strain in mice. Vaccine 25: 612-620.
7. Flynn KJ, Belz GT, Altman JD, Ahmed R, Woodland DL, et al. (1998) Virus-specific CD8+ T cells in primary and secondary influenza pneumonia. Immunity 8: 683-691.
8. Kedzierska K, La Gruta NL, Turner SJ, Doherty PC, (2006) Establishment and recall of CD8+ T-cell memory in a model of localized transient infection. Immunol Rev 211: 133-145.
9. Rimmelzwaan GF, Kreijtz JH, Bodewes R, Fouchier RA, Osterhaus AD, (2009) Influenza virus CTL epitopes, remarkably conserved and remarkably variable. Vaccine 27: 6363-6365.
10. Voeten JT, Bestebroer TM, Nieuwkoop NJ, Fouchier RA, Osterhaus AD, et al. (2000) Antigenic drift in the influenza A virus (H3N2) nucleoprotein and escape from recognition by cytotoxic T lymphocytes. J Virol 74: 6800-6807.
11. Kedzierska K, Guillonneau C, Gras S, Hatton LA, Webby R, et al. (2008) Complete modification of TCR specificity and repertoire selection does not perturb a CD8+ T cell immunodominance hierarchy. Proc Natl Acad Sci U S A 105: 19408-19413.
12. Webby RJ, Andreansky S, Stambas J, Rehg JE, Webster RG, et al. (2003) Protection and compensation in the influenza virus-specific CD8+ T cell response. Proc Natl Acad Sci U S A 100: 7235-7240.
13. Price GE, Ou R, Jiang H, Huang L, Moskophidis D, (2000) Viral escape by selection of cytotoxic T cell-resistant variants in influenza A virus pneumonia. J Exp Med 191: 1853-1867.
14. Garten RJ, Davis CT, Russell CA, Shu B, Lindstrom S, et al. (2009) Antigenic and genetic characteristics of swine-origin 2009 A(H1N1) influenza viruses circulating in humans. Science 325: 197-201.
15. Greenbaum JA, Kotturi MF, Kim Y, Oseroff C, Vaughan K, et al. (2009) Pre-existing immunity against swine-origin H1N1 influenza viruses in the general human population. Proc Natl Acad Sci U S A 106: 20365-20370.
16. Ge X, Tan V, Bollyky PL, Standifer NE, James EA, et al. (2010) Assessment Of Seasonal Influenza A Specific CD4 T Cell Responses To 2009 Pandemic H1N1 Swine-Origin Influenza A Virus. J Virol 84: 3312-3319.
17. Richards KA, Topham D, Chaves FA, Sant AJ, (2010) Cutting edge: CD4 T cells generated from encounter with seasonal influenza viruses and vaccines have broad protein specificity and can directly recognize naturally generated epitopes derived from the live pandemic H1N1 virus. J Immunol 185: 4998-5002.
18. Guo H, Santiago F, Lambert K, Takimoto T, Topham DJ, (2011) T cell-mediated protection against lethal 2009 pandemic H1N1 influenza virus infection in a mouse model. J Virol 85: 448-455.
19. Skountzou I, Koutsonanos DG, Kim JH, Powers R, Satyabhama L, et al. (2010) Immunity to Pre-1950 H1N1 Influenza Viruses Confers Cross-Protection against the Pandemic Swine-Origin 2009 A (H1N1) Influenza Virus. J Immunol.
20. Ellebedy AH, Fabrizio TP, Kayali G, Oguin TH 3rd, Brown SA, et al (2010) Contemporary seasonal influenza A (H1N1) virus infection primes for a more robust response to split inactivated pandemic influenza A (H1N1) Virus vaccination in ferrets. Clin Vaccine Immunol 17: 1998-2006.
21. Sun K, Ye J, Perez DR, Metzger DW, (2011) Seasonal FluMist Vaccination Induces Cross-Reactive T Cell Immunity against H1N1 (2009) Influenza and Secondary Bacterial Infections. J Immunol 186: 987-993.
22. Zhong W, Reche PA, Lai CC, Reinhold B, Reinherz EL, (2003) Genome-wide characterization of a viral cytotoxic T lymphocyte epitope repertoire. J Biol Chem 278: 45135-45144.
23. Vitiello A, Yuan L, Chesnut RW, Sidney J, Southwood S, et al. (1996) Immunodominance analysis of CTL responses to influenza PR8 virus reveals two new dominant and subdominant Kb-restricted epitopes. J Immunol 157: 5555-5562.
24. Woodland DL, Hogan RJ, Zhong W, (2001) Cellular immunity and memory to respiratory virus infections. Immunol Res 24: 53-67.
25. Welsh RM, Che JW, Brehm MA, Selin LK, (2010) Heterologous immunity between viruses. Immunol Rev 235: 244-266.
26. Rubio V, Stuge TB, Singh N, Betts MR, Weber JS, et al. (2003) Ex vivo identification, isolation and analysis of tumor-cytolytic T cells. Nat Med 9: 1377-1382.
27. Betts MR, Brenchley JM, Price DA, De Rosa SC, Douek DC, et al. (2003) Sensitive and viable identification of antigen-specific CD8+ T cells by a flow cytometric assay for degranulation. J Immunol Methods 281: 65-78.
28. Turner SJ, Kedzierska K, Komodromou H, La Gruta NL, Dunstone MA, et al. (2005) Lack of prominent peptide-major histocompatibility complex features limits repertoire diversity in virus-specific CD8+ T cell populations. Nat Immunol 6: 382-389.
29. Bennink JR, Yewdell JW, Smith GL, Moss B, (1987) Anti-influenza virus cytotoxic T lymphocytes recognize the three viral polymerases and a nonstructural protein: responsiveness to individual viral antigens is major histocompatibility complex controlled. J Virol 61: 1098-1102.
30. Theodossis A, Guillonneau C, Welland A, Ely LK, Clements CS, et al. (2010) Constraints within major histocompatibility complex class I restricted peptides: presentation and consequences for T-cell recognition. Proc Natl Acad Sci U S A 107: 5534-5539.
31. Andreansky S, Stambas J, Gutierrez A, Diaz G, Doherty PC, et al. (2004) Generation of recombinant influenza A viruses lacking immunodominant CD8+ T cell epitopes. International Congress Series 1263: 141-144.
32. Haanen JB, Wolkers MC, Kruisbeek AM, Schumacher TN, (1999) Selective expansion of cross-reactive CD8(+) memory T cells by viral variants. J Exp Med 190: 1319-1328.
33. Boon AC, de Mutsert G, van Baarle D, Smith DJ, Lapedes AS, et al. (2004) Recognition of homo- and heterosubtypic variants of influenza A viruses by human CD8+ T lymphocytes. J Immunol 172: 2453-2460.
34. Polakos NK, Klein I, Richter MV, Zaiss DM, Giannandrea M, et al. (2007) Early intrahepatic accumulation of CD8+ T cells provides a source of effectors for nonhepatic immune responses. J Immunol 179: 201-210.
35. Lundegaard C, Lamberth K, Harndahl M, Buus S, Lund O, et al. (2008) NetMHC-3.0: accurate web accessible predictions of human, mouse and monkey MHC class I affinities for peptides of length 8-11. Nucleic Acids Res 36: W509-512.
36. Guo H, Topham DJ, (2010) Interleukin-22 (IL-22) production by pulmonary Natural Killer cells and the potential role of IL-22 during primary influenza virus infection. J Virol 84: 7750-7759.